Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1391417-19-8 | MDL No. : | MFCD12910667 |
Formula : | C12H15ClF3N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NBVVWIDMOJBRLN-RFVHGSKJSA-N |
M.W : | 265.70 | Pubchem ID : | 127264619 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.5 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 67.21 |
TPSA : | 12.03 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.18 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.86 |
Log Po/w (WLOGP) : | 4.77 |
Log Po/w (MLOGP) : | 3.6 |
Log Po/w (SILICOS-IT) : | 3.67 |
Consensus Log Po/w : | 3.18 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.05 |
Solubility : | 0.0238 mg/ml ; 0.0000895 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -3.81 |
Solubility : | 0.0412 mg/ml ; 0.000155 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.5 |
Solubility : | 0.0084 mg/ml ; 0.0000316 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 1391407-62-7 ]
(R)-2-(4-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 1197237-16-3 ]
2-(3-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 220247-87-0 ]
7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
Similarity: 0.92
[ 1074764-69-4 ]
5-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
Similarity: 0.90
[ 1391407-62-7 ]
(R)-2-(4-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 1197237-16-3 ]
2-(3-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 127733-46-4 ]
(R)-1-(2-(Trifluoromethyl)phenyl)ethanamine
Similarity: 0.86
[ 185110-19-4 ]
2-(4-Trifluoromethylphenyl)piperazine
Similarity: 0.85
[ 1391407-62-7 ]
(R)-2-(4-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 1197237-16-3 ]
2-(3-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 220247-87-0 ]
7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
Similarity: 0.92
[ 1074764-69-4 ]
5-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline hydrochloride
Similarity: 0.90
[ 1391407-62-7 ]
(R)-2-(4-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 1197237-16-3 ]
2-(3-(Trifluoromethyl)phenyl)pyrrolidine hydrochloride
Similarity: 0.94
[ 185110-19-4 ]
2-(4-Trifluoromethylphenyl)piperazine
Similarity: 0.85
[ 255051-14-0 ]
4-(2-(Trifluoromethyl)phenyl)piperidine hydrochloride
Similarity: 0.79
[ 1218935-60-4 ]
(R)-2-(2,5-Difluorophenyl)pyrrolidine hydrochloride
Similarity: 0.72
[ 255051-14-0 ]
4-(2-(Trifluoromethyl)phenyl)piperidine hydrochloride
Similarity: 0.79
[ 1185010-62-1 ]
2-(2-Fluorophenyl)piperidine hydrochloride
Similarity: 0.75